Errata (DOI:10.1016/j.juro.2006.03.085);The E-Cadherin -160 C/A Polymorphism and Prostate Cancer Risk in White and Black American Men

Journal of Urology

Volumn 176, Issue 2, 2006, Pages 793-796

  Pookot, Deepa ^a   Li, Long Cheng ^a   Tabatabai, Z Laura ^a   Tanaka, Yuichiro ^a   Greene, Kirsten L ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cadherins; continental population groups; genetic; polymorphisms; prostate; prostatic neoplasms

Indexed keywords

UVOMORULIN;

AFRICAN AMERICAN; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33745232322     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.023     Document Type: Erratum

References (20)

1. Neugut A.I., Chen A.C., and Petrylak D.P. The "skinny" on obesity and prostate cancer prognosis. J Clin Oncol 22 (2004) 395
2. Rodriguez C., Calle E.E., Miracle-McMahill H.L., Tatham L.M., Wingo P.A., Thun M.J., et al. Family history and risk of fatal prostate cancer. Epidemiology 8 (1997) 653
3. Hoffman R.M., Gilliland F.D., Eley J.W., Harlan L.C., Stephenson R.A., Stanford J.L., et al. Racial and ethnic differences in advanced-stage prostate cancer. the Prostate Cancer Outcomes Study. J Natl Cancer Inst 93 (2001) 388
4. Cotter M.P., Gern R.W., Ho G.Y., Chang R.Y., and Burk R.D. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate 50 (2002) 216
5. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451
6. Pignatelli M., Ansari T.W., Gunter P., Liu D., Hirano S., Takeichi M., et al. Loss of membranous E-cadherin expression in pancreatic cancer. correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174 (1994) 243
7. Bringuier P.P., Umbas R., Schaafsma H.E., Karthaus H.F., Debruyne F.M., and Schalken J.A. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53 (1993) 3241
8. Umbas R., Isaacs W.B., Bringuier P.P., Schaafsma H.E., Karthaus H.F., Oosterhof G.O., et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54 (1994) 3929
9. Nakamura A., Shimazaki T., Kaneko K., Shibata M., Matsumura T., Nagai M., et al. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 502 (2002) 19
10. Li L.C., Chui R.M., Sasaki M., Nakajima K., Perinchery G., Au H.C., et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60 (2000) 873
11. Zhang X., Ma X., Zhu Q.G., Li L.C., Chen Z., and Ye Z.Q. Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol 170 (2003) 1379
12. Wu M.S., Huang S.P., Chang Y.T., Lin M.T., Shun C.T., Chang M.C., et al. Association of the -160 C -> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94 (2002) 1443
13. Humar B., Graziano F., Cascinu S., Catalano V., Ruzzo A.M., Magnani M., et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 21 (2002) 8192
14. Tsukino H., Kuroda Y., Nakao H., Imai H., Inatomi H., Kohshi K., et al. E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Lett 195 (2003) 53
15. Verhage B.A., van Houwelingen K., Ruijter T.E., Kiemeney L.A., and Schalken J.A. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 100 (2002) 683
16. Jonsson B.A., Adami H.O., Hagglund M., Bergh A., Goransson I., Stattin P., et al. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. Int J Cancer 109 (2004) 348
17. Lindstrom S., Wiklund F., Jonsson B.A., Adami H.O., Balter K., Brookes A.J., et al. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk. strong confirmation of functional promoter SNP. Hum Genet (2005) 1
18. Kamoto T., Isogawa Y., Shimizu Y., Minamiguchi S., Kinoshita H., Kakehi Y., et al. Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population. Jpn J Clin Oncol 35 (2005) 158
19. Hajdinjak T., and Toplak N. E-cadherin polymorphism-160 C/A and prostate cancer. Int J Cancer 109 (2004) 480
20. Tsukino H., Kuroda Y., Imai H., Nakao H., Qiu D., Komiya Y., et al. Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer. Urol Int 72 (2004) 203